Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FLUPHENAZINE HYDROCHORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluphenazine hydrochloride from Rising Pharma Holdings, Inc., under ANDA 218283.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

SUPPL AP for FLUPHENAZINE HYDROCHORIDE (FLUPHENAZINE HYDROCHLORIDE)